These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32843296)

  • 21. Flow Pattern of Outflow Graft is Useful for Detecting Pump Thrombosis in a Patient with Left Ventricular Assist Device.
    Sato T; Fujino T; Higo T; Ohtani K; Hiasa KI; Sakamoto T; Chishaki A; Shiose A; Tsutsui H
    Int Heart J; 2019 Jul; 60(4):994-997. PubMed ID: 31257336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis.
    Estep JD; Vivo RP; Cordero-Reyes AM; Bhimaraj A; Trachtenberg BH; Torre-Amione G; Chang SM; Elias B; Bruckner BA; Suarez EE; Loebe M
    J Heart Lung Transplant; 2014 Jun; 33(6):575-86. PubMed ID: 24656286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices.
    Kortekaas KA; den Exter PL; Beeres SLMA; Palmen M; Jukema JW; Huisman MV; Tops LF
    Front Cardiovasc Med; 2022; 9():969766. PubMed ID: 36312273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
    Joyce E; Stewart GC; Hickey M; Coakley L; Rivero JM; Gosev I; Givertz MM; Couper GS; Mehra MR
    J Heart Lung Transplant; 2015 Dec; 34(12):1561-9. PubMed ID: 26508725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis.
    Jorde UP; Aaronson KD; Najjar SS; Pagani FD; Hayward C; Zimpfer D; Schlöglhofer T; Pham DT; Goldstein DJ; Leadley K; Chow MJ; Brown MC; Uriel N
    JACC Heart Fail; 2015 Nov; 3(11):849-56. PubMed ID: 26454842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Various Treatment Strategies for Patients with Continuous-Flow Ventricular Assist Device Thrombosis: A Retrospective Analysis.
    Ertugay S; Engin C; Daylan A; Pektok E; Ozturk P; Nalbantgil S; Zoghi M; Yagdi T; Ozbaran M
    ASAIO J; 2016; 62(5):533-8. PubMed ID: 27258228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical technique influences HeartMate II left ventricular assist device thrombosis.
    Taghavi S; Ward C; Jayarajan SN; Gaughan J; Wilson LM; Mangi AA
    Ann Thorac Surg; 2013 Oct; 96(4):1259-1265. PubMed ID: 23968757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cavitation in left ventricular assist device patients: a potential early sign of pump thrombosis.
    Zuin M; Rigatelli G; Braggion G; Bacich D; Nguyen T
    Heart Fail Rev; 2020 Nov; 25(6):965-972. PubMed ID: 31691065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 36. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
    Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
    ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.
    Pedde D; Soltani S; Stein J; Tsyganenko D; Müller M; Schönrath F; Falk V; Potapov EV
    Eur J Cardiothorac Surg; 2020 Feb; 57(2):325-330. PubMed ID: 31317177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.